Brief: Insilico Medicine And Ribo Enter Strategic Collaboration Agreement
12/05/2026 14:24
May 12 (Reuters) - Insilico Medicine Cayman TopCo 3696.HK: INSILICO MEDICINE AND RIBO ENTER STRATEGIC COLLABORATION AGREEMENT: LEVERAGING AI PLATFORM AND AUTOMATED LAB FOR END-TO-END EMPOWERMENT OF RNA INTERFERENCE AND OLIGONUCLEOTIDE THERAPEUTICS DEVELOPMENT Source text: ID:nPn41fyJha Further company coverage: 3696.HK ((Reuters.Briefs@thomsonreuters.com;))
Recent news on Insilico Medicine Cayman TopCo
See all newsInSilico Medicine jumps on progress in testing of new weight-loss drug
Development Collaboration
InSilico jumps on collaboration to develop biological frontier foundation models
HK-listed InSilico Medicine climbs as chairman buys shares
Brief: Insilico Medicine Cayman Topco's Chair Purchases Aggregate 113,500 Shares In Sept 4-7